PDK3 Kinase Assay Kit
The PDK3 Kinase Assay Kit is designed to measure PDK3 activity for screening and profiling applications using ADP-Glo® as a detection reagent. The signal is measured using a luminometer or a microplate reader capable of reading chemiluminescence.
ADP-Glo® Kinase Assay (ADP-Glo reagent and Kinase Detection reagent) (Promega #V6930)
Dithiothreitol (DTT 0.5 M)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator
Catalog # | Name | Amount | Storage |
100927 | PDK3* | 50 µg | -80°C |
79334 | 5x Kinase assay buffer | 1.5 ml | -20°C |
79686 | ATP (500 µM) | 100 µl | -20°C |
Casein (10 mg/ml) | 250 µl | -20°C | |
79696 | 96-well plate, white | 1 | Room Temp. |
* The initial concentration of enzyme is lot-specific and will be indicated on the tube containing the protein.
The pyruvate dehydrogenase (PDH) complex is a mitochondrial complex that converts pyruvate to acetyl-CoA. It is a primary regulator of glucose metabolism by providing the link between glycolysis and the tricarboxylic acid cycle. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, in which phosphorylation results in inactivation of PDH. PDK3 inhibits the PDH complex by phosphorylation of the E1 alpha subunit.
PDK3 participates in the metabolic switch of cancer cells; although its significance in tumor malignancy is unknown. PDK3 has been implicated in drug resistance following the treatment of leukemia or colon cancer.
1. Feng, Lan, et al. "miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3." Bioscience Reports9 (2019): BSR20190654.
2. Lu, Chun-Wun, et al. "Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer." J. Pathol. 179.3 (2011): 1405-1414.
3. Mohammad, Taj, et al. "Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: Towards therapeutic management of cancer." Biomolec. Struct. Dynam. 39.2 (2021): 586-594.